CIAM
TWST icon

Caitong International Asset Management’s Twist Bioscience TWST Stock Holding History

Caitong International Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,990
Closed -$94.6K – 3455
2026
Q1 		$94.6K Buy
1,990
+1,364
+218% +$61.2K 0.02% 587
2025
Q4 		$19.9K Buy
+626
New +$19.5K ﹤0.01% 987

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Caitong International Asset Management's TWST Position: Q2 2026 in Review

Caitong International Asset Management sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 1,990 shares — an estimated $94.6K sold.

Caitong International Asset Management first reported a position in TWST in Q4 2025 and held it in 2 quarters. The position peaked at $94.6K in Q1 2026. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Caitong International Asset Management reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,990 Twist Bioscience shares in Q2 2026, an estimated $94.6K.
  • Caitong International Asset Management first reported a position in Twist Bioscience in Q4 2025 and held it in 2 quarters.
  • Caitong International Asset Management's Twist Bioscience position peaked at $94.6K in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.